Sfoglia per Rivista
Clinical trials and haemophilia : does the Bayesian approach make the ideal and desirable good friends?
2009 A. Iorio, M. Marcucci
Combined FV and FVIII deficiency
2008 M. Spreafico, F. Peyvandi
A comparative evaluation of a new automated assay for von Willebrand factor activity
2013 A.S. Lawrie, F. Stufano, M.T. Canciani, I.J. Mackie, S.J. Machin, F. Peyvandi
A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method
2018 F. Stufano, L. Baronciani, D. Mane-Padros, G. Cozzi, S. Faraudo, F. Peyvandi
A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease
2011 A. Tosetto, F. Rodeghiero, G. Castaman, A. Goodeve, A.B. Federici, J. Batlle, D. Meyer, J. Goudemand, J. Eikenboom, R. Schneppenheim, U. Budde, J. Ingerslev, S. Lethagen, F. G. Hill, I. Peake
Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy
2004 M. Karimi, F. Peyvandi, S.M. Siboni, R. Ardeshiri, A. Gringeri, P.M. Mannucci
Congenital factor XIII deficiency in Pakistan : characterization of seven families and identification of four novel mutations
2014 M. Borhany, H. Handrkova, A. Cairo, V. Schroeder, N. Fatima, A. Naz, S. Amanat, T. Shamsi, F. Peyvandi, H.P. Kohler
Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations
2008 G. Castaman, S.H. Giacomelli, S. Duga, F. Rodeghiero
Congenital platelet disorders : overview of their mechanisms, diagnostic evaluation and treatment
2006 C.P.M. Hayward, A.K. Rao, M. Cattaneo
Consensus perspectives on prophylactic therapy for haemophilia : summary statement
2003 E. Berntorp, J. Astermark, S. Björkman, V. S. Blanchette, K. Fischer, P. L. F. Giangrande, A. Gringeri, R. C. Ljung, M. J. Manco-Johnson, M. Morfini, R. F. Kilcoyne, P. Petrini, E. C. Rodriguez-Merchan, W. Schramm, A. Shapiro, H. M. van Den Berg, C. Hart
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement
2004 E.C. Rodriguez Merchan, A. Rocino, B. Ewenstein, L. Bartha, A. Batorova, J. Goudemand, A. Gringeri, M. Joao Diniz, S. Lopaciuk, C. Negrier, M. Quintana, G. Tagariello, G.E. Tjonnfjord, V.A. Villar, Z. Vorlova
Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project
2019 E. Santagostino, A. Riva, S. Cesaro, S. Esposito, D. Matino, R.I. Mazzucchelli, A.C. Molinari, R. Mura, L.D. Notarangelo, A. Tagliaferri, G. Di Minno, M. Clerici
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
2006 J. Astermark, M. Morado, A. Rocino, H.M. van den Berg, M. von Depka, A. Gringeri, L. Mantovani, R.P. Garrido, M. Schiavoni, A. Villar, J. Windyga, EHTSB
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors
2007 A. Astermark, A. Rocino, M. Von Depka, H.M. Van Den Berg, A. Gringeri, L.G. Mantovani, M. Morado, R.P. Garrido, M. Schiavoni, A. Villar, J. Windyga
Delivery of AAV-based gene therapy through haemophilia centres—A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC
2021 W. Miesbach, P. Chowdary, M. Coppens, D.P. Hart, V. Jimenez-Yuste, R. Klamroth, M. Makris, D. Noone, F. Peyvandi
Desmopressin : an historical introduction
2008 P.M. Mannucci
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia : a discrete choice experiment
2005 G. Tagariello, R. Musso, G. Piseddu, A. Rocino, G. Rodorigo, G. Rossetti, F.A. Scaraggi, P. Schinco, A. Tagliaferri, R. Targhetta, M. Morfini, V.T. Lombardo, E. Zanon, M. Schiavoni, L. Bizzoni, A. Iorio, P. Iannaccaro, E. Santagostino, M. D'Inca, D. Bertuzzo, G. Feola, A. Coppola, L. Contino, G. Castaman, G. Mancuso, E. Boeri, A. Dragani, A. Billio, F. Baudo, G. Barillari, A. Gringeri, M. Villa, L. Scalone, P.M. Mannucci, M.S. Monzini, L.G. Mantovani, B. Caputo, G. Delios
Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation
2018 M.T. Pagliari, L. Baronciani, F. Stufano, P. Colpani, S.M. Siboni, F. Payvandi
Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ?
2014 B. O'Mahony, F. Peyvandi, A. Bok
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
2022 M.T. Pagliari, L. Baronciani, C. Cordiglieri, P. Colpani, G. Cozzi, S.M. Siboni, F. Peyvandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile